American Century Companies Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 16.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,703,113 shares of the healthcare conglomerate’s stock after purchasing an additional 681,111 shares during the quarter. UnitedHealth Group makes up 0.9% of American Century Companies Inc.’s investment portfolio, making the stock its 10th largest position. American Century Companies Inc. owned about 0.48% of UnitedHealth Group worth $872,051,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Waldron LP boosted its stake in UnitedHealth Group by 153.1% in the 1st quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock worth $944,000 after purchasing an additional 3,487 shares during the period. Empire Life Investments Inc. boosted its position in shares of UnitedHealth Group by 3.9% during the 1st quarter. Empire Life Investments Inc. now owns 25,171 shares of the healthcare conglomerate’s stock valued at $3,530,000 after acquiring an additional 949 shares during the last quarter. Elkhorn Investments LLC bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $1,122,000. Public Employees Retirement Association of Colorado boosted its position in shares of UnitedHealth Group by 13.9% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 783,190 shares of the healthcare conglomerate’s stock valued at $128,451,000 after acquiring an additional 95,874 shares during the last quarter. Finally, MCF Advisors LLC boosted its position in shares of UnitedHealth Group by 55.2% during the 1st quarter. MCF Advisors LLC now owns 1,214 shares of the healthcare conglomerate’s stock valued at $199,000 after acquiring an additional 432 shares during the last quarter. Institutional investors and hedge funds own 86.17% of the company’s stock.
In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 72,149 shares of company stock valued at $14,212,342. 0.89% of the stock is owned by company insiders.
Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down $0.49 during trading hours on Friday, hitting $211.07. The stock had a trading volume of 1,384,700 shares, compared to its average volume of 3,134,052. The company has a market capitalization of $205,015.92, a P/E ratio of 22.04, a P/E/G ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.72 and a current ratio of 0.70. UnitedHealth Group Incorporated has a 1 year low of $146.01 and a 1 year high of $213.93.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.17 earnings per share. sell-side analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
WARNING: “UnitedHealth Group Incorporated (UNH) is American Century Companies Inc.’s 10th Largest Position” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2017/11/11/unitedhealth-group-inc-unh-is-american-century-companies-inc-s-10th-largest-position.html.
A number of analysts have recently issued reports on UNH shares. UBS AG reiterated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Bank of America Corporation boosted their target price on UnitedHealth Group from $210.00 to $214.00 and gave the stock a “buy” rating in a research report on Friday, July 14th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley boosted their target price on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $216.65.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.